- Presentations
- 2
- Markets
- 1
Tecentriq is a brand of Atezolizumab marketed by Genentech, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Atezolizumab
- Brand owner
- Genentech
- Registered in
- United States
- Strengths and forms
- 1200 mg/20 mL injection, 840 mg/14 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tecentriq 1200 mg/20 mL injectionIntravenous Cold chain | Genentech | US FDA | Available on request |
| Tecentriq 840 mg/14 mL injectionIntravenous Cold chain | Genentech | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tecentriq
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.